A potential iron-based mechanism for enhanced deposition of amyloid plaques due to cognitive stimulation in Alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 63, Issue 6, 2004, Pages 674-675

  Dobson, Jon ^a   Batich, Christopher ^b  

^a KEELE UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BETA SECRETASE; IRON;

ALZHEIMER DISEASE; COGNITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IRON STORAGE; LETTER; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SENILE PLAQUE;

EID: 2942592383     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/63.6.674     Document Type: Letter

References (15)

1. Jankowsky JL, Xu G, Fromholt D, Gonzales V, Borchelt DR. Environmental enrichment exacerbates amyloid plaque formation in a transgenic mouse model of Alzheimer disease. J Neuropathol Exp Neurol 2003;16:1220-27
2. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993;43:13-20
3. Kamenetz F, Tomita T, Hsieh H, et al. APP processing and synaptic function. Neuron 2003;37:925-37
4. Brandan E, Inestrosa NC. Extracellular matrix components and amyloid in neuritic plaques of Alzheimer's disease. Gen Pharmacol 1993;24:1063-68
5. Meyer-Luehmann M, Stalder M, Herzig MC, et al. Extracellular amyloid formation and associated pathology in neural grafts. Nat Neurosci 2003;6:370-77
6. Vargas JD, Herpers B, McKie AT, et al. Stromal cell-derived receptor 2 and cytochrome b561 are functional ferric reductases. Biochim Biophys Acta 2003;1651:116-23
7. Connor JR. Iron acquisition and expression of iron regulatory proteins in the developing brain-Manipulation by ethanol exposure, iron deprivation and cellular dysfunction. Devel Neurosci 1994;16:233-47
8. Harrison PM, Arosio P. The ferritins: Molecular properties, iron storage function and cellular regulation. Biochim Biophys Acta 1996;1275:161-203
9. Rouault TA. Iron on the brain. Nat Neurosci 2001;28:299-300
10. Smith MA, Harris PLR, Sayre LM, Perry G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997;94:9866-68
11. Sayre LM, Perry G, Harris PLR, Liu YH, Schubert KA, Smith MA. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: Aβ central role for bound transition metals. J Neurochem 2000;74:270-79
12. Hautot D, Pankhurst QA, Kahn N, Dobson J. Preliminary evaluation of nanoscale biogenic magnetite and Alzheimer's disease. Proc R Soc London B Biol Sci 2003;270:S62-S64
13. Dobson J. Nanoscale biogenic iron oxides and neurodegenerative disease. FEBS Lett 2001;496:1-5
14. Rottkamp CA, Atwood CS, Joseph JA, et al. The state versus amyloid-β: The trial of the most wanted criminal in Alzheimer disease. Peptides 2003;23:1333-41
15. Bishop GM, Robinson SR. Amyloid helps to protect neurons from oxidative stress. Neurobiol Aging 2000;21:S226